Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
US12128141B1 · kind B1 · utility
0Cited by
62References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2024 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Jul 31, 2044 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a muco-adhesive coating and the muco-adhesive coating is externally coated with an enteric coating; and (b) an immediate release component comprising levodopa. The invention further provides a method for making and using the oral solid formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.